Findings

What do systematic reviews say?

3 questions · 3 findings · 1 reviews · Sexually Transmitted Infections

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 33.3%Low 2 · 66.7%Moderate 0 · 0%High 0 · 0%

Clinical cure: syndromic approach · sexually active adults

Macrolide (erythromycin) showed no clear difference in clinical cure: syndromic approach compared with any other macrolide (low certainty).

1 finding from 1 review

Macrolides for treatment of Haemophilus ducreyi infection in sexually active adults 2017 · Cochrane Headline outcomes only
RR 1 [0.91, 1.1]
2 studies · 269 participants
Low

Clinical cure: aetiological approach · sexually active adults

Macrolide (erythromycin) showed no clear difference in clinical cure: aetiological approach compared with any other macrolide (low certainty).

1 finding from 1 review

Macrolides for treatment of Haemophilus ducreyi infection in sexually active adults 2017 · Cochrane Headline outcomes only
RR 1.04 [0.93, 1.16]
2 studies · 211 participants
Low

Minor adverse events · sexually active adults

It is very uncertain whether macrolide (erythromycin) changes minor adverse events compared with any other macrolide (very low certainty).

1 finding from 1 review

Macrolides for treatment of Haemophilus ducreyi infection in sexually active adults 2017 · Cochrane Headline outcomes only
RR 1.14 [0.63, 2.06]
1 study · 101 participants
Very low